Liraglutide in combination with metformin reduces lipolysis and lipid oxidation in patients with well controlled type 2 diabetes and ischaemic heart diseaseC. Anholm,P. Kumarathurai,L. R. Pedersen,A. Samkani,O. P. Kristiansen,O. W. Nielsen,M. Fenger,S. Madsbad,A. Sajadieh, R. C. Boston,S. B. HaugaardDIABETOLOGIA(2018)引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要